An Analysis of the Results of Mammographically Guided Biopsies of the Breast

Digital stereotactic biopsies for nonpalpable breast lesion

“…Often, specific diagnosis is not possible with cytology, and it is not successful in the differential diagnosis between typical and atypical proliferative lesions and between invasive or in situ carcinomas. Surgical biopsy, which represents the gold standard, with preoperative localization of the lesion has many relevant problems related to the choice of anesthesia (local or general), the type of preoperative localization, the possibility of dislocation of the repere, the excision of a large sample of tissue, and accuracy (missed lesion, 5-17%) [17]. Thus an x-ray of the specimen is usually requested.…”

Nine Years’ Experience of Needle Localized Breast Biopsy in a University Hospital: Results and Evaluation of the Role of the Surgeon in Decision Making

“…Breast cancer occurs at a rate of 14% to 36% in clinically non-palpable but mammographically detected abnormalities (8,9). Needle-guided biopsy is one of the most commonly used means of locating these lesions.…”

Site‐select procedure for non‐palpable breast lesions: Feasibility study with a 15‐mm cannula

“…On the basis of follow-up mammography, no malignancies were missed among our 27 patients. The estimated miss rates of vacuum-assisted biopsy is about 3%, although it is difficult to determinate this rate due to incomplete or non-reported follow-up of the benign lesions that were not surgically removed [13], and 5%-17% for surgical biopsy [17].…”